Latest Insider Transactions at Health Catalyst, Inc. (HCAT)
This section provides a real-time view of insider transactions for Health Catalyst, Inc. (HCAT). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Health Catalyst, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Health Catalyst, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
May 12
2023
|
Daniel D. Burton Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
49,050
+5.06%
|
$490,500
$10.19 P/Share
|
May 03
2023
|
Benjamin Landry General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
20,000
+38.84%
|
-
|
May 03
2023
|
Anne Marie Bickmore COO and Chief Product Officer |
BUY
Grant, award, or other acquisition
|
Direct |
35,000
+32.93%
|
-
|
Mar 22
2023
|
Paul Horstmeier Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
50,000
+19.62%
|
$200,000
$4.42 P/Share
|
Mar 03
2023
|
Bryan Truman Hunt Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
760
-0.33%
|
$10,640
$14.34 P/Share
|
Mar 03
2023
|
Jason Alger Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
2,967
-5.09%
|
$41,538
$14.23 P/Share
|
Mar 01
2023
|
Paul Horstmeier Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,464
-2.8%
|
$62,496
$14.29 P/Share
|
Mar 01
2023
|
Daniel D. Burton Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
7,717
-0.88%
|
$108,038
$14.29 P/Share
|
Mar 01
2023
|
Daniel H. Orenstein General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
2,186
-1.62%
|
$30,604
$14.29 P/Share
|
Mar 01
2023
|
Kevin Lee Freeman Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
3,083
+0.85%
|
-
|
Mar 01
2023
|
Kevin Lee Freeman Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,569
-0.87%
|
$21,966
$14.29 P/Share
|
Mar 01
2023
|
Linda Llewelyn Chief People Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,734
-2.06%
|
$24,276
$14.29 P/Share
|
Mar 01
2023
|
Bryan Truman Hunt Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,351
-1.41%
|
$46,914
$14.29 P/Share
|
Mar 01
2023
|
Jason Alger Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,142
+1.92%
|
-
|
Mar 01
2023
|
Jason Alger Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,614
-2.75%
|
$22,596
$14.29 P/Share
|
Feb 22
2023
|
Linda Llewelyn Chief People Officer |
BUY
Grant, award, or other acquisition
|
Direct |
35,000
+29.4%
|
-
|
Feb 22
2023
|
Daniel H. Orenstein General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
40,000
+22.82%
|
-
|
Feb 22
2023
|
Bryan Truman Hunt Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
100,000
+29.68%
|
-
|
Feb 22
2023
|
Jason Alger Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
25,000
+29.85%
|
-
|
Feb 15
2023
|
Linda Llewelyn Chief People Officer |
SELL
Open market or private sale
|
Direct |
662
-1.33%
|
$8,606
$13.82 P/Share
|
Jan 18
2023
|
Bryan Truman Hunt Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
2,354
-1.69%
|
$28,248
$12.53 P/Share
|
Jan 17
2023
|
Bryan Truman Hunt Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
2,055
-1.45%
|
$24,660
$12.0 P/Share
|
Jan 17
2023
|
Linda Llewelyn Chief People Officer |
SELL
Open market or private sale
|
Direct |
642
-1.28%
|
$7,704
$12.12 P/Share
|
Dec 15
2022
|
Linda Llewelyn Chief People Officer |
SELL
Open market or private sale
|
Direct |
642
-1.26%
|
$7,062
$11.0 P/Share
|
Dec 06
2022
|
Jason Alger Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
259
-0.76%
|
$2,590
$10.39 P/Share
|
Dec 01
2022
|
Linda Llewelyn Chief People Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,557
-6.52%
|
$35,570
$10.65 P/Share
|
Dec 01
2022
|
Paul Horstmeier Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
15,561
-8.9%
|
$155,610
$10.65 P/Share
|
Dec 01
2022
|
Daniel H. Orenstein General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
4,325
-4.34%
|
$43,250
$10.65 P/Share
|
Dec 01
2022
|
Bryan Truman Hunt Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
9,129
-6.07%
|
$91,290
$10.65 P/Share
|
Dec 01
2022
|
Daniel D. Burton Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
22,058
-2.45%
|
$220,580
$10.65 P/Share
|
Dec 01
2022
|
Jason Alger Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,501
-6.85%
|
$25,010
$10.65 P/Share
|
Dec 01
2022
|
Kevin Lee Freeman Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,446
-1.35%
|
$24,460
$10.65 P/Share
|
Nov 15
2022
|
Linda Llewelyn Chief People Officer |
SELL
Open market or private sale
|
Direct |
669
-1.21%
|
$6,690
$10.82 P/Share
|
Nov 11
2022
|
Daniel D. Burton Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
197,078
+17.96%
|
$1,970,780
$10.14 P/Share
|
Oct 18
2022
|
Linda Llewelyn Chief People Officer |
SELL
Open market or private sale
|
Direct |
648
-1.16%
|
$5,832
$9.53 P/Share
|
Sep 15
2022
|
Linda Llewelyn Chief People Officer |
SELL
Open market or private sale
|
Direct |
648
-1.15%
|
$6,480
$10.99 P/Share
|
Sep 08
2022
|
Kevin Lee Freeman Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
120,000
+39.75%
|
-
|
Sep 08
2022
|
Daniel D. Burton Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
90,750
+11.43%
|
$907,500
$10.99 P/Share
|
Sep 06
2022
|
Daniel H. Orenstein General Counsel |
SELL
Open market or private sale
|
Direct |
2,838
-2.77%
|
$31,218
$11.27 P/Share
|
Sep 06
2022
|
Jason Alger Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
262
-0.71%
|
$2,882
$11.28 P/Share
|
Sep 01
2022
|
Linda Llewelyn Chief People Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
848
-1.48%
|
$9,328
$11.61 P/Share
|
Sep 01
2022
|
Daniel H. Orenstein General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
1,225
-1.18%
|
$13,475
$11.61 P/Share
|
Sep 01
2022
|
Bryan Richard Hinton Chief Technology Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,413
-5.08%
|
$15,543
$11.61 P/Share
|
Sep 01
2022
|
Bryan Truman Hunt Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,414
-0.93%
|
$15,554
$11.61 P/Share
|
Sep 01
2022
|
James Patrick Nelli Jr. President |
SELL
Payment of exercise price or tax liability
|
Direct |
3,359
-1.25%
|
$36,949
$11.61 P/Share
|
Sep 01
2022
|
Paul Horstmeier Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,869
-1.61%
|
$31,559
$11.61 P/Share
|
Sep 01
2022
|
Daniel D. Burton Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
7,362
-1.19%
|
$80,982
$11.61 P/Share
|
Sep 01
2022
|
Jason Alger Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
567
-1.52%
|
$6,237
$11.61 P/Share
|
Aug 19
2022
|
Duncan Gallagher |
BUY
Open market or private purchase
|
Direct |
6,600
+15.71%
|
$72,600
$11.63 P/Share
|
Aug 18
2022
|
Duncan Gallagher |
BUY
Open market or private purchase
|
Direct |
8,400
+22.58%
|
$92,400
$11.69 P/Share
|